Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB086550 in Advanced Solid Tumors
NCT03762447Phase 1Completed
- Sponsor
- Incyte
- Start
- Dec 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 1, open-label, single-arm trial of incb086550 in solid tumor, sponsored by Incyte. Primary endpoint: Treatment-Emergent Adverse Events. Started Dec 2018; status: completed.
02
Drugs
incb086550
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03762447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762447.